Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

Ensuring Quality Assurance in Life Sciences: Best Practices and Common Pitfalls

Feb 27, 2025

Introduction to Quality Assurance in Life Sciences

Quality assurance (QA) in the life sciences is paramount due to the impact these industries have on public health and safety. Whether it's pharmaceuticals, biotechnology, or medical devices, ensuring that products meet high standards is crucial. This blog post explores best practices and common pitfalls in maintaining quality assurance within the life sciences sector.

QA processes ensure that the products developed are safe, effective, and compliant with regulatory standards. These processes are not only essential for consumer safety but also for maintaining a company's reputation and avoiding costly recalls or legal issues.

quality control lab

Best Practices for Quality Assurance

Implementing a Robust Quality Management System

A robust Quality Management System (QMS) is foundational for any life sciences company. It should include documented procedures, clear roles and responsibilities, and continuous monitoring and improvement mechanisms. A well-structured QMS helps in identifying potential quality issues early on, ensuring that corrective actions are timely and effective.

Employee Training and Development

Employees must be well-trained in QA processes and understand the importance of compliance with regulatory standards. Regular training sessions and workshops can keep staff informed about the latest industry standards and technological advancements. This not only enhances their skills but also instills a culture of quality within the organization.

employee training

Leveraging Technology for Quality Assurance

Technological advancements have significantly improved QA processes in life sciences. Automated systems and software can streamline data collection, analysis, and reporting, reducing human error and increasing efficiency. Implementing technologies like AI and machine learning can further enhance predictive analytics, helping to foresee potential quality issues before they arise.

Moreover, digital tools can facilitate better communication and collaboration across departments, ensuring that all stakeholders are aligned with the QA objectives. This holistic approach to technology integration is essential for maintaining consistent product quality.

technology in lab

Common Pitfalls in Quality Assurance

Overlooking Regulatory Compliance

One of the most common pitfalls in QA is neglecting to keep up with changing regulatory requirements. The life sciences industry is heavily regulated, and non-compliance can result in severe penalties. Companies must stay informed about regulatory updates and ensure their QMS is adaptable to these changes.

Inadequate Documentation

Poor documentation can lead to misunderstandings, errors, and non-compliance issues. It's crucial to maintain comprehensive and accurate records of all QA activities. This not only helps during audits but also provides a reliable reference for continuous improvement efforts.

documentation

Conclusion: Ensuring Excellence in Life Sciences

Quality assurance is not a one-time effort but an ongoing commitment to excellence. By implementing best practices, leveraging technology, and avoiding common pitfalls, life sciences companies can ensure their products meet the highest quality standards. This commitment not only safeguards public health but also enhances brand reputation and drives business success.

Ultimately, a strong focus on quality assurance contributes to innovation and progress within the life sciences industry, paving the way for safer and more effective solutions for consumers worldwide.